Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

BACKGROUND: Breast cancer often metastasizes into bone and leads to osteolytic lesions. The underlying mechanisms, however, are complex and not fully understood. Syndecan-1 is a proteoglycan that has various functions relevant for tumor progression including cell–cell communication and cell–matrix i...

Descripción completa

Detalles Bibliográficos
Autores principales: Benad-Mehner, Peggy, Thiele, Stefanie, Rachner, Tilman D., Göbel, Andy, Rauner, Martina, Hofbauer, Lorenz C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723417/
https://www.ncbi.nlm.nih.gov/pubmed/26909290
http://dx.doi.org/10.1016/j.jbo.2013.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723417/
https://www.ncbi.nlm.nih.gov/pubmed/26909290
http://dx.doi.org/10.1016/j.jbo.2013.11.001

Ejemplares similares